HSBC Holdings
PMVP icon

HSBC Holdings’s PMV Pharmaceuticals PMVP Stock Holding History

HSBC Holdings’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$38.5K Hold
30,891
– – ﹤0.01% 2824
2025
Q4 		$39.4K Hold
30,891
– – ﹤0.01% 2877
2025
Q3 		$43.1K Hold
30,891
– – ﹤0.01% 2651
2025
Q2 		$32.7K Hold
30,891
– – ﹤0.01% 2963
2025
Q1 		$32.7K Sell
30,891
-8,189
-21% -$11.1K ﹤0.01% 2939
2024
Q4 		$58K Hold
39,080
– – ﹤0.01% 2971
2024
Q3 		$58.6K Sell
39,080
-4,633
-11% -$7.16K ﹤0.01% 2868
2024
Q2 		$71.9K Hold
43,713
– – ﹤0.01% 2786
2024
Q1 		$74.3K Buy
43,713
+4,634
+12% +$8.65K ﹤0.01% 2889
2023
Q4 		$118K Buy
39,079
+8,400
+27% +$22.2K ﹤0.01% 2574
2023
Q3 		$184K Sell
30,679
-8,377
-21% -$57.6K ﹤0.01% 2434
2023
Q2 		$243K Buy
39,056
+11,053
+39% +$57.9K ﹤0.01% 2241
2023
Q1 		$134K Buy
+28,003
New +$197K ﹤0.01% 2466

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

HSBC Holdings's PMVP Position: Q1 2026 in Review

HSBC Holdings held its PMV Pharmaceuticals (PMVP) position steady in Q1 2026 at 30,891 shares worth $38.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2824.

HSBC Holdings first reported a position in PMVP in Q1 2023 and has held it in 13 quarters since. The position peaked at $243K in Q2 2023. 69 funds tracked by Wall St. Rank hold PMVP as of Q1 2026.

  • HSBC Holdings held 30,891 shares of PMV Pharmaceuticals worth $38.5K as of Q1 2026.
  • HSBC Holdings left its PMV Pharmaceuticals share count unchanged in Q1 2026.
  • PMV Pharmaceuticals made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2824 holding.
  • HSBC Holdings first reported a position in PMV Pharmaceuticals in Q1 2023 and has held it in 13 quarters since.
  • HSBC Holdings's PMV Pharmaceuticals position peaked at $243K in Q2 2023.
  • 69 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.